Coloplast : A very interesting acquisition
>Acquisition of Kerecis offers superior skin substitute - Coloplast announced the acquisition of Kerecis, a US-based company in the biologics wound care segment. It has developed and patented a clinically differentiated, sustainable, and scalable technology platform based on intact fish skin from Icelandic cod fish. Produced with minimal processing, the fish skin retains its similarity to human skin, resulting in improved wound healing. The technology is backed by com...Coloplast is a supplier of intimate healthcare products and services. Co. develops and markets products that support people with diseases of a private nature. Co. operates in three business areas: Ostomy care, products for people whose intestinal outlet has been rerouted through the abdominal wall; Urology and continence care products, for people suffering from diseases of the kidneys, the urinary system and the male reproductive system; Dressings, for the treatment of chronic wounds and skin care products for prevention and treatment. Co. markets and sells its products and services globally. Co. supplies products to hospitals, institutions as well as wholesalers and retailers.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.